Divisions of Cellular and Molecular Immunology, and.
Blood. 2013 Oct 10;122(15):2618-21. doi: 10.1182/blood-2013-06-508143. Epub 2013 Aug 23.
Defects in perforin and related genes lead to a loss of normal immune regulation and underlie hemophagocytic lymphohistiocytosis (HLH), which requires hematopoietic cell transplantation for long-term cure. However, transplantation may be complicated by the development of mixed chimerism and uncertainty regarding the risk of HLH recurrence. To help clarify this risk and investigate how perforin influences immune activation, we studied perforin-mediated immune regulation in the context of mixed chimerism using a murine model of HLH. We found that there is a distinct threshold of ∼10% to 20% perforin expression with either mixed hematopoietic or CD8(+) T cell chimerism, above which immune regulation was reestablished. These findings demonstrate that perforin-mediated immunoregulation functions in trans and are consistent with a feedback model in which cytotoxic T cells control immune activation by killing dendritic cells. These findings also suggest rational targets for maintenance of minimal posttransplant chimerism and for therapeutic strategies involving gene correction.
穿孔素和相关基因的缺陷导致正常免疫调节的丧失,并构成噬血细胞性淋巴组织细胞增生症(HLH)的基础,该病需要造血细胞移植才能长期治愈。然而,移植可能会因混合嵌合体的发展以及 HLH 复发的风险不确定而变得复杂。为了帮助澄清这种风险并研究穿孔素如何影响免疫激活,我们使用 HLH 的小鼠模型研究了混合嵌合体背景下穿孔素介导的免疫调节。我们发现,存在一个明显的阈值,约为 10%至 20%的穿孔素表达,无论是混合造血细胞还是 CD8(+)T 细胞嵌合体,超过这个阈值即可重建免疫调节。这些发现表明穿孔素介导的免疫调节是通过细胞间作用进行的,与细胞毒性 T 细胞通过杀死树突状细胞来控制免疫激活的反馈模型一致。这些发现还为维持最小的移植后嵌合体和涉及基因矫正的治疗策略提供了合理的目标。